April 28 – May 1, Mallorca, Spain
Montpellier, April 22nd, 2024 – Quantum Surgical will attend the European Conference on Interventional Oncology (ECIO) held in Mallorca from April 28th to May 1st, dedicated to top interventional oncology KOLs. Quantum Surgical will present its Epione® robotic ablation platform and organize its first European symposium, during which three key users will share their robotic experience: Pr. Thierry de Baere (Gustave Roussy, France), Pr. Laurent Milot (Hospices Civils de Lyon, France) and Dr. Gilles Piana (Institut Paoli-Calmettes, France).
French medical robotics company Quantum Surgical will take part in the ECIO, which brings together top interventional oncology KOLs and experts on minimally invasive cancer care for knowledge exchange in the field.
Quantum Surgical will thus present its Epione® robotic platform dedicated to the early and curative treatment of tumors during the event held in Mallorca April 28 – May 1st and will host its first European symposium on “Epione®: How Robotics is Creating the Next Generation of IO Programs”.
During the symposium, users of Epione®, Pr. Thierry de Baere (Gustave Roussy, France), Pr. Laurent Milot (Hospices Civils de Lyon, France) and Dr. Gilles Piana (Institut Paoli-Calmettes, France) will share how robotics has changed their way to perform and to teach percutaneous ablation procedures, as well as how they have been able to implement a robotics program in their institutions.
The symposium will be organized on Sunday, April 28, 18:30 – 18:55, Auditorium 2.
Epione® is a robot-assisted technology that allows physicians to perform safe and effective percutaneous tumor ablations, a minimally invasive treatment in which one or several needles are inserted through the skin to the tumor to destroy it.
Epione® is CE marked in Europe for abdomen and lung tumors, and FDA cleared for abdominal tumors. of patients have already been treated worldwide.
More information about Quantum Surgical at ECIO and registration for the sessions available here.
About Quantum Surgical
Quantum Surgical is a French medical robotics company co-founded in 2017 by Bertin Nahum, CEO. With a dynamic team of over 110 employees, the company is headquartered in Montpellier, France, and has offices in Miami, Florida. Combining robotics and AI, its Epione® platform is dedicated to the curative and early treatment of cancers.
Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. Hundreds of patients have already been treated worldwide.
Quantum Surgical was awarded the prestigious Prix Galien USA in 2022, the equivalent of the Nobel Prize for biopharmaceutical research, and joined in 2023 the governmental French Tech 2030 program in 2023 that supports top emerging actors in disruptive innovation.
More information: www.quantumsurgical.com
Press contact Quantum Surgical
Stéphanie Moy
s.moy@quantumsurgical.com
Tel. : +33 (0)6 32 55 85 48
